One of the major goals of VTLCRC is to develop translational research that will have as one of its major requirements, patient specimens with clinical follow up. Animal experiments require careful histopathological Interpretation, sometimes with special histochemical and immunohistochemical techniques. The tumor bank core facility was set up to support such research activities and will play a crucial role in the future development of VTLCRC. The goals of the tumor bank core facility are: (1) to maintain a comprehensive bank of frozen and fixed tumor tissues with relevant clinical and laboratory information for use by VTLCRC investigators, 2) to provide a number of histopathology related services, and 3) to provide VTLCRC investigators expert help in conducting experiments utilizing specimens from human and animal subjects. The fresh frozen tumor banks has been in operation since February, 1991 in the pathology department. In addition the lymphoma tumor bank and prostate tumor bank have been in operation by other VTLCRC programs. To unify these three banks, increase the tumor accrual, and expand the range of provided services, the VTLCRC tumor bank core was established under the direction of Dr. Soonmyoung Paik, a board certified anatomic pathologist. IRB approval for obtaining patient follow up was obtained on Feb 20, 1992. A pathology assistant working full time in the surgical pathology grossing room is one of the unique features of this core. Since she is available 100% of the time to save tissue specimens, tissue accrual process is highly optimized. A comprehensive database is maintained for the banked specimens. The facility described in this proposal has thus far been supported only by a combination of CCSG Developmental Funds and the Cancer Center's discretionary funding.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA051008-04
Application #
3773531
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Zheng, Wenjie; Wu, Xiuhua; Goudarzi, Maryam et al. (2018) Metabolomic alterations associated with Behçet's disease. Arthritis Res Ther 20:214
Kozlik, Petr; Goldman, Radoslav; Sanda, Miloslav (2018) Hydrophilic interaction liquid chromatography in the separation of glycopeptides and their isomers. Anal Bioanal Chem 410:5001-5008
Getnet, Derese; Gautam, Aarti; Kumar, Raina et al. (2018) Poisoning with Soman, an Organophosphorus Nerve Agent, Alters Fecal Bacterial Biota and Urine Metabolites: a case for Novel Signatures for Asymptomatic Nerve Agent Exposure. Appl Environ Microbiol :
Bluethmann, Shirley M; Sciamanna, Christopher N; Winkels, Renate M et al. (2018) Healthy Living After Cancer Treatment: Considerations for Clinical and Community Practice. Am J Lifestyle Med 12:215-219
Graves, Kristi D; Hall, Michael J; Tercyak, Kenneth P (2018) Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for translational behavioral medicine research, practice, and policy. Transl Behav Med 8:4-6
Aldeghaither, Dalal S; Zahavi, David J; Murray, Joseph C et al. (2018) A Mechanism of Resistance to Antibody-Targeted Immune Attack. Cancer Immunol Res :
Bhuvaneshwar, Krithika; Song, Lei; Madhavan, Subha et al. (2018) viGEN: An Open Source Pipeline for the Detection and Quantification of Viral RNA in Human Tumors. Front Microbiol 9:1172
Sosin, Michael; Gupta, Surupa Sen; Wang, Jessica S et al. (2018) A Prospective Analysis of Quality of Life and Toxicity Outcomes in Treating Early Breast Cancer With Breast Conservation Therapy and Intraoperative Radiation Therapy. Front Oncol 8:545
Lipkus, Isaac M; Mays, Darren (2018) Comparing harm beliefs and risk perceptions among young adult waterpipe tobacco smokers and nonsmokers: Implications for cessation and prevention. Addict Behav Rep 7:103-110
Tassi, Elena; Garman, Khalid A; Schmidt, Marcel O et al. (2018) Fibroblast Growth Factor Binding Protein 3 (FGFBP3) impacts carbohydrate and lipid metabolism. Sci Rep 8:15973

Showing the most recent 10 out of 1120 publications